Form 4: LivaNova Executive Settles RSUs, Adjusts Holdings

LivaNova PLC's President of Cardiopulmonary, Franco Poletti, settled 643 restricted stock units, leading to a net adjustment in his ordinary share holdings.

Summary

• Franco Poletti, President of Cardiopulmonary at LivaNova PLC, reported changes in his beneficial ownership of company shares.
• On September 15, 2025, 643 vested restricted stock units (RSUs) were settled into ordinary shares.
• Concurrently, 277 ordinary shares were disposed of at a price of $55.43 per share to satisfy tax liabilities related to the RSU vesting.
• Following these transactions, Poletti directly owns 8,299 ordinary shares and indirectly owns 219 ordinary shares through his spouse.
• He also beneficially owns 1,932 derivative securities in the form of Restricted Stock Units.
• The RSUs were granted on September 15, 2024, with a four-year vesting schedule in equal annual installments, and the reported transaction marks the first vesting event.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and tax-related share disposition, which is neutral in terms of company performance or outlook.

Positives

• Vesting of 643 Restricted Stock Units (RSUs) indicates the executive's continued equity participation and alignment with shareholder interests.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged and systematic approach to equity management.

Negatives

• 277 ordinary shares were disposed of to cover tax liabilities, representing a reduction in direct share ownership.

Future Outlook

The remaining 1,932 Restricted Stock Units are subject to future vesting in equal annual installments, indicating continued equity incentives for the executive over the next three years.

Industry Context

This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitors.

Stakeholder Impact

• Shareholders: Minor, routine adjustment in an executive's holdings; no material impact on overall share structure or company valuation.
• Employees: Reflects standard executive compensation practices, potentially reinforcing retention.

Next Steps

• Future annual vesting installments of the remaining 1,932 Restricted Stock Units.

Key Dates

Recommendation

This Form 4 details a routine executive compensation event (RSU vesting and tax-related share sale) that does not reflect any new fundamental information about LivaNova PLC's operations, financial health, or strategic direction. It is a pre-scheduled transaction under a 10b5-1 plan, thus not indicative of discretionary insider sentiment. Therefore, it provides no basis for changing an investment thesis, warranting a "hold" recommendation.

Keywords

LivaNova, LIVN, Franco Poletti, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Form 4, Share Ownership